2026-08-12 04:00 UTCOriginal source2 min readUpdated: 2026-08-12 08:41 UTC

DoseBridge: Denoising Diffusion Bridge Model for Dose Prediction in Lung Intensity-Modulated Proton Therapy

arXiv:2608.10173v1 Announce Type: new Abstract: Most radiotherapy dose-prediction models use only CT images and anatomical structures, although intensity-modulated proton therapy (IMPT) dose also depends strongly on beam geometry and available clinical datasets are often small. We present DoseBridge, a denoising diffusion bridge model that uses the patient CT as a structured bridge endpoint and encodes plan-specific beam geometry in a spatially aligned beam mask. Multiscale fusion combines CT, target, organ-at-risk, and beam-mask representations with 1.95% additional parameters. DoseBridge was retrospectively evaluated on single-institution CT images and treatment plans from 52 patients with advanced-stage lung cancer treated with 60 Gy in 30 fractions; 42 cases were used for training and 10 for testing. Performance was assessed using image-similarity, dose-volume, and Lyman-Kutcher-Burman normal-tissue complication probability (NTCP) metrics and compared with two deep-learning models. On the test cohort, DoseBridge achieved a mean absolute error of 4.170 Gy, peak signal-to-noise ratio of 23.06 dB, and structural similarity index of 0.798, outperforming both comparison models on these metrics. Clinical target volume D95 differed from the reference dose by 0.62 +/- 1.6 Gy; signed organ-at-risk mean-dose differences ranged from -0.32 to 0.24 Gy, and NTCP differences were -0.40 +/- 2.2 and 0.52 +/- 3.4 percentage points for acute esophagitis and radiation pneumonitis, respectively. Changing only the beam mask redirected predicted low-dose entrance regions while preserving the high-dose target region. To our knowledge, DoseBridge is the first denoising diffusion bridge model for radiotherapy dose prediction. These results support its feasibility as a beam-aware planning prior for lung IMPT, pending evaluation in larger external cohorts.

SourcearXiv Computer VisionAuthor: Zerun Zhang, Xiaoda Cong, Xiangkun Xu, Peter Y. Chen, Xuanfeng Ding

-->

[Submitted on 10 Aug 2026]

Title:DoseBridge: Denoising Diffusion Bridge Model for Dose Prediction in Lung Intensity-Modulated Proton Therapy

View a PDF of the paper titled DoseBridge: Denoising Diffusion Bridge Model for Dose Prediction in Lung Intensity-Modulated Proton Therapy, by Zerun Zhang and 3 other authors

View PDF HTML (experimental)

Abstract:Most radiotherapy dose-prediction models use only CT images and anatomical structures, although intensity-modulated proton therapy (IMPT) dose also depends strongly on beam geometry and available clinical datasets are often small. We present DoseBridge, a denoising diffusion bridge model that uses the patient CT as a structured bridge endpoint and encodes plan-specific beam geometry in a spatially aligned beam mask. Multiscale fusion combines CT, target, organ-at-risk, and beam-mask representations with 1.95% additional parameters. DoseBridge was retrospectively evaluated on single-institution CT images and treatment plans from 52 patients with advanced-stage lung cancer treated with 60 Gy in 30 fractions; 42 cases were used for training and 10 for testing. Performance was assessed using image-similarity, dose-volume, and Lyman-Kutcher-Burman normal-tissue complication probability (NTCP) metrics and compared with two deep-learning models. On the test cohort, DoseBridge achieved a mean absolute error of 4.170 Gy, peak signal-to-noise ratio of 23.06 dB, and structural similarity index of 0.798, outperforming both comparison models on these metrics. Clinical target volume D95 differed from the reference dose by 0.62 +/- 1.6 Gy; signed organ-at-risk mean-dose differences ranged from -0.32 to 0.24 Gy, and NTCP differences were -0.40 +/- 2.2 and 0.52 +/- 3.4 percentage points for acute esophagitis and radiation pneumonitis, respectively. Changing only the beam mask redirected predicted low-dose entrance regions while preserving the high-dose target region. To our knowledge, DoseBridge is the first denoising diffusion bridge model for radiotherapy dose prediction. These results support its feasibility as a beam-aware planning prior for lung IMPT, pending evaluation in larger external cohorts.

Subjects:

Computer Vision and Pattern Recognition (cs.CV)

Cite as: arXiv:2608.10173 [cs.CV]

(or arXiv:2608.10173v1 [cs.CV] for this version)

https://doi.org/10.48550/arXiv.2608.10173

arXiv-issued DOI via DataCite (pending registration)

Submission history

From: Zerun Zhang [view email] [v1] Mon, 10 Aug 2026 19:43:10 UTC (19,291 KB)

Full-text links:

Access Paper:

View a PDF of the paper titled DoseBridge: Denoising Diffusion Bridge Model for Dose Prediction in Lung Intensity-Modulated Proton Therapy, by Zerun Zhang and 3 other authors

View PDF

HTML (experimental)

TeX Source

view license

Current browse context:

cs.CV

new | recent | 2026-08

Change to browse by:

References & Citations

NASA ADS

Google Scholar

Semantic Scholar

Data provided by:

Bibliographic Tools

Bibliographic and Citation Tools

Bibliographic Explorer Toggle

Bibliographic Explorer (What is the Explorer?)

Connected Papers Toggle

Connected Papers (What is Connected Papers?)

Litmaps Toggle

Litmaps (What is Litmaps?)

scite.ai Toggle

scite Smart Citations (What are Smart Citations?)

Code, Data, Media

Code, Data and Media Associated with this Article

alphaXiv Toggle

alphaXiv (What is alphaXiv?)

Links to Code Toggle

CatalyzeX Code Finder for Papers (What is CatalyzeX?)

DagsHub Toggle

DagsHub (What is DagsHub?)

GotitPub Toggle

Gotit.pub (What is GotitPub?)

Huggingface Toggle

Hugging Face (What is Huggingface?)

ScienceCast Toggle

ScienceCast (What is ScienceCast?)

Demos

Replicate Toggle

Replicate (What is Replicate?)

Spaces Toggle

Hugging Face Spaces (What is Spaces?)

Spaces Toggle

TXYZ.AI (What is TXYZ.AI?)